Skip to main content

Want a detailed portfolio tracker?

Biodesix (BDSX) P/E (2020 - 2026)

Biodesix (BDSX) P/E from Oct 28, 2020 to Jun 3, 2026. The TTM Biodesix (BDSX) P/E is -4.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Biodesix (BDSX)

YearP/EChange
2026-4.11+181.84%
2025-1.46-67.40%
2024-4.48+93.61%
2023-2.31+65.72%
2022-1.40-59.38%
2021-3.43-27.39%
2020-4.73N/A

Comparison Biodesix (BDSX) P/E with competitors

Biodesix (BDSX) P/E is -4.11.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc0.78-118.95%
MBAICheckCap Ltd2.88-170.09%
FONRFonar Corp15.41-474.72%
QGENQiagen NV17.55-526.62%
IQVIQVIA Holdings Inc20.25-592.31%
DGXQuest Diagnostics Inc21.62-625.62%
LHLaboratory Corp Of America Holdings22.66-650.96%
AAgilent Technologies Inc25.45-718.71%
MEDPMedpace Holdings Inc26.32-739.97%
TMOThermo Fisher Scientific Inc26.87-753.28%
MTDMettler-Toledo International Inc26.96-755.47%
DHRDanaher Corp33.26-908.52%
ILMNIllumina Inc34.97-950.26%
ICLRIcon Plc39.55-1061.43%
IDXXIdexx Laboratories Inc40.14-1075.77%
VCYTVeracyte Inc40.15-1076.23%
RVTYRevvity Inc45.79-1213.29%
SHCSotera Health Company63.43-1642.10%
WATWaters Corp93.81-2380.67%